Clinical Research in Paediatric Psychopharmacology - 1st Edition - ISBN: 9780081006160

Clinical Research in Paediatric Psychopharmacology

1st Edition

An Overview of the Ethical, Scientific and Regulatory Aspects

Authors: Philippe Auby
Hardcover ISBN: 9780081006160
Imprint: Woodhead Publishing
Published Date: 1st June 2018
Page Count: 512
Tax/VAT will be calculated at check-out Price includes VAT (GST)

Institutional Access

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.


Clinical Research in Paediatric Psychopharmacology: An Overview of the Ethical, Scientific and Regulatory Aspects will be developed and organised with the aim to be a practical guide first providing an overview of ethical, scientific and regulatory aspects of clinical research in paediatric psychopharmacology, and second discussing practical points to consider when developing clinical research in this field.

The targeted audience should be rather broad targeting professionals involved in clinical research in paediatric psychopharmacology i.e. including but not limited to paediatricians, health care professionals, researchers, investigators, pharmaceutical company personals, and potentially ethics committee members.

Other audience could be targeted by two specific chapters:

  • The role of patient’s organization and advocacy groups in research
  • The role of families and patients: ‘should I involve my kid in a clinical research?
Historical, ethical, regulatory, clinical, scientific, intercultural and practical aspects of clinical research in child and adolescent psychopharmacology will be covered.

Key Features

  • Covers both theoretical and practical aspects
  • Develops different angles from the regulatory frame to the patient perspective
  • Proposes insights rather than tips
  • Offers future perspective for paediatric development


Professionals involved in clinical research and healthcare professionals

Table of Contents

  1. Introduction
    2. Historical perspective
    3. Regulatory changing environment – US – EU – rest of World & WHO
    4. Scientific – state of the art – child and adolescent psychopharmacology at the beginning of the 21st century
    5. Ethical aspects of research in paediatric psychopharmacology – including ethics committee interactions, consent and assent procedures
    6. Clinical development – practical considerations – writing protocols – running clinical trials – specific paediatric formulation - proactive patient recruitment strategies… (the largest chapter)
    7. Patients and family perspective – if it was my child?
    8. Intercultural aspects – risks of clinical trial colonialism – global paediatric devlopment
    9. Future methodological perspectives – including simulation, modeling and extrapolation – innovation in child and adolescent psychiatry
    10. Future of child and adolescent psychopharmacological research
    11. Conclusion
    12. References


No. of pages:
© Woodhead Publishing 2018
Woodhead Publishing
Hardcover ISBN:

About the Author

Philippe Auby

Dr Philippe Aubyis a Child and Adolescent Psychiatrist. He started his residency training in Psychiatry in 1986 and received his MD from the Toulouse University of Medicine, France. In 1989 and 1990, for his military service, the author worked as a psychiatrist in South East Refugee Camps in Thailand. After an initial training in adult psychiatry, he completed a board certification in child and adolescent psychiatry and a post-graduate diploma in psychology. His main research interests are in child and adolescent psychiatry, schizophrenia, bipolar disorders, PTSD, consultation/liaison psychiatry and inter-cultural psychiatry. In 1996 he joined a CRO based in Paris before moving first to Eli Lilly France then to BMS France. In 2001, he moved to BMS European Headquarter in Belgium prior working for Otsuka America Pharmaceutical, in Princeton as Executive Director-CNS Abilify in 2004. Early 2007, he moved to Lundbeck to create the International Clinical Research Department of Paediatric Neuro-Psychiatry. His current title is Senior Medical Director, Corporate ICR France & Paediatrics.

Affiliations and Expertise

Corporate ICR France & Paediatrics, France